197 related articles for article (PubMed ID: 15504760)
1. Inhibitory effect of BIBN4096BS on cephalic vasodilatation induced by CGRP or transcranial electrical stimulation in the rat.
Petersen KA; Birk S; Doods H; Edvinsson L; Olesen J
Br J Pharmacol; 2004 Nov; 143(6):697-704. PubMed ID: 15504760
[TBL] [Abstract][Full Text] [Related]
2. Role of K ATP channels in cephalic vasodilatation induced by calcitonin gene-related peptide, nitric oxide, and transcranial electrical stimulation in the rat.
Gozalov A; Jansen-Olesen I; Klaerke D; Olesen J
Headache; 2008 Sep; 48(8):1202-13. PubMed ID: 18647185
[TBL] [Abstract][Full Text] [Related]
3. BIBN4096BS antagonizes human alpha-calcitonin gene related peptide-induced headache and extracerebral artery dilatation.
Petersen KA; Lassen LH; Birk S; Lesko L; Olesen J
Clin Pharmacol Ther; 2005 Mar; 77(3):202-13. PubMed ID: 15735614
[TBL] [Abstract][Full Text] [Related]
4. Inhibitory effect of BIBN4096BS, CGRP(8-37), a CGRP antibody and an RNA-Spiegelmer on CGRP induced vasodilatation in the perfused and non-perfused rat middle cerebral artery.
Edvinsson L; Nilsson E; Jansen-Olesen I
Br J Pharmacol; 2007 Mar; 150(5):633-40. PubMed ID: 17245362
[TBL] [Abstract][Full Text] [Related]
5. Efficacy of the non-peptide CGRP receptor antagonist BIBN4096BS in blocking CGRP-induced dilations in human and bovine cerebral arteries: potential implications in acute migraine treatment.
Moreno MJ; Abounader R; Hébert E; Doods H; Hamel E
Neuropharmacology; 2002 Mar; 42(4):568-76. PubMed ID: 11955527
[TBL] [Abstract][Full Text] [Related]
6. Effects of the calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS on alpha-CGRP-induced regional haemodynamic changes in anaesthetised rats.
Arulmani U; Schuijt MP; Heiligers JP; Willems EW; Villalón CM; Saxena PR
Basic Clin Pharmacol Toxicol; 2004 Jun; 94(6):291-7. PubMed ID: 15228501
[TBL] [Abstract][Full Text] [Related]
7. The calcitonin gene-related peptide (CGRP) receptor antagonist BIBN4096BS reduces neurogenic increases in dural blood flow.
Tröltzsch M; Denekas T; Messlinger K
Eur J Pharmacol; 2007 May; 562(1-2):103-10. PubMed ID: 17349622
[TBL] [Abstract][Full Text] [Related]
8. Characterisation of CGRP receptors in the human isolated middle meningeal artery.
Gupta S; Mehrotra S; Avezaat CJ; Villalón CM; Saxena PR; Maassenvandenbrink A
Life Sci; 2006 Jun; 79(3):265-71. PubMed ID: 16458930
[TBL] [Abstract][Full Text] [Related]
9. The in vivo effect of adrenomedullin on rat dural and pial arteries.
Juhl L; Petersen KA; Larsen EH; Jansen-Olesen I; Olesen J
Eur J Pharmacol; 2006 May; 538(1-3):101-7. PubMed ID: 16643888
[TBL] [Abstract][Full Text] [Related]
10. Characterisation of CGRP receptors in human and porcine isolated coronary arteries: evidence for CGRP receptor heterogeneity.
Gupta S; Mehrotra S; Villalón CM; Garrelds IM; de Vries R; van Kats JP; Sharma HS; Saxena PR; Maassenvandenbrink A
Eur J Pharmacol; 2006 Jan; 530(1-2):107-16. PubMed ID: 16375887
[TBL] [Abstract][Full Text] [Related]
11. The CGRP-antagonist, BIBN4096BS does not affect cerebral or systemic haemodynamics in healthy volunteers.
Petersen KA; Birk S; Lassen LH; Kruuse C; Jonassen O; Lesko L; Olesen J
Cephalalgia; 2005 Feb; 25(2):139-47. PubMed ID: 15658951
[TBL] [Abstract][Full Text] [Related]
12. Noncompetitive antagonism of BIBN4096BS on CGRP-induced responses in human subcutaneous arteries.
Sheykhzade M; Lind H; Edvinsson L
Br J Pharmacol; 2004 Dec; 143(8):1066-73. PubMed ID: 15477223
[TBL] [Abstract][Full Text] [Related]
13. Effects of BIBN4096BS on cardiac output distribution and on CGRP-induced carotid haemodynamic responses in the pig.
Kapoor K; Arulmani U; Heiligers JP; Willems EW; Doods H; Villalón CM; Saxena PR
Eur J Pharmacol; 2003 Aug; 475(1-3):69-77. PubMed ID: 12954361
[TBL] [Abstract][Full Text] [Related]
14. Intravital microscopy on a closed cranial window in mice: a model to study trigeminovascular mechanisms involved in migraine.
Gupta S; Akerman S; van den Maagdenberg AM; Saxena PR; Goadsby PJ; van den Brink AM
Cephalalgia; 2006 Nov; 26(11):1294-303. PubMed ID: 17059436
[TBL] [Abstract][Full Text] [Related]
15. Rat mesenteric small artery neurogenic dilatation is predominantly mediated by β
Søndergaard AM; Overgaard CB; Mazur A; Postnov DD; Matchkov VV; Aalkjaer C
J Physiol; 2019 Apr; 597(7):1819-1831. PubMed ID: 30693527
[TBL] [Abstract][Full Text] [Related]
16. Calcitonin gene-related peptide (CGRP) modulates nociceptive trigeminovascular transmission in the cat.
Storer RJ; Akerman S; Goadsby PJ
Br J Pharmacol; 2004 Aug; 142(7):1171-81. PubMed ID: 15237097
[TBL] [Abstract][Full Text] [Related]
17. A comparison of the actions of BIBN4096BS and CGRP(8-37) on CGRP and adrenomedullin receptors expressed on SK-N-MC, L6, Col 29 and Rat 2 cells.
Hay DL; Howitt SG; Conner AC; Doods H; Schindler M; Poyner DR
Br J Pharmacol; 2002 Sep; 137(1):80-6. PubMed ID: 12183333
[TBL] [Abstract][Full Text] [Related]
18. Effect of the CGRP receptor antagonist BIBN4096BS in human cerebral, coronary and omental arteries and in SK-N-MC cells.
Edvinsson L; Alm R; Shaw D; Rutledge RZ; Koblan KS; Longmore J; Kane SA
Eur J Pharmacol; 2002 Jan; 434(1-2):49-53. PubMed ID: 11755165
[TBL] [Abstract][Full Text] [Related]
19. Effect of two novel CGRP-binding compounds in a closed cranial window rat model.
Juhl L; Edvinsson L; Olesen J; Jansen-Olesen I
Eur J Pharmacol; 2007 Jul; 567(1-2):117-24. PubMed ID: 17477918
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist.
Doods H; Hallermayer G; Wu D; Entzeroth M; Rudolf K; Engel W; Eberlein W
Br J Pharmacol; 2000 Feb; 129(3):420-3. PubMed ID: 10711339
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
